Search clinical trials for: cyclophosphamide, bortezomib and dexamethasone (CyBorD)
Total 473797 results
-
Gilead SciencesCompletedMultiple MyelomaUnited States, Czechia, Canada
-
Poitiers University HospitalSanofi; Intergroupe Francophone du MyelomeActive, not recruitingMultiple Myeloma | Myeloma | Myeloma MultipleFrance
-
University of LeedsCelgene; Janssen, LP; Myeloma UKActive, not recruiting
-
University of UlmCentre Hospitalier de Lens (Co-Sponsor)CompletedWaldenström's MacroglobulinemiaGermany
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Italy, Czechia, Denmark, France, Germany, Greece, Spain
-
TakedaActive, not recruiting
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Netherlands, Belgium, Korea, Republic of, United Kingdom, Sweden, Denmark, Italy, Japan, Germany, France, Spain, Australia, Israel, Poland, Greece
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Spain, United Kingdom
-
Ida Bruun KristensenOdense Patient Data Explorative Network; Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaDenmark, Norway, Estonia
-
Antengene CorporationActive, not recruiting
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLCActive, not recruiting
-
Massachusetts General HospitalBristol-Myers Squibb; Celgene; Multiple Myeloma Research ConsortiumActive, not recruitingMultiple MyelomaUnited States
-
Bristol-Myers SquibbAbbVieActive, not recruitingMultiple MyelomaUnited States, Canada, Australia, Poland, Italy, Belgium, Spain, Japan, Greece, Hungary, Romania, Turkey, United Kingdom
-
University of ArkansasActive, not recruitingMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterTakedaActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Spain
-
National Cancer Institute (NCI)Active, not recruitingAdult T Acute Lymphoblastic Leukemia | Childhood T Acute Lymphoblastic Leukemia | Ann Arbor Stage II Adult Lymphoblastic Lymphoma | Ann Arbor Stage II Childhood Lymphoblastic Lymphoma | Ann Arbor Stage III Adult Lymphoblastic Lymphoma | Ann Arbor Stage III Childhood Lymphoblastic Lymphoma | Ann... and other conditionsUnited States, Canada, Australia, New Zealand
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, Poland, Ukraine, Germany, Spain, Turkey, Korea, Republic of, Brazil, Russian Federation, Netherlands, Hungary, Sweden, Czechia, Mexico
-
St. Jude Children's Research HospitalIncyte Corporation; Amgen; ServierActive, not recruitingAcute Lymphoblastic Leukemia | Acute Lymphoblastic LymphomaUnited States, Australia
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.; CelgeneActive, not recruiting
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsActive, not recruitingMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJanssen Scientific Affairs, LLCActive, not recruitingMultiple MyelomaUnited States
-
Washington University School of MedicineSanofiTerminatedMultiple MyelomaUnited States
-
Institute of Hematology & Blood Diseases Hospital...TerminatedAcquired Pure Red Cell AplasiaChina
-
SanofiCompleted
-
St. Jude Children's Research HospitalBaylor College of Medicine; Gateway for Cancer ResearchActive, not recruitingAcute Lymphoblastic LeukemiaUnited States, Canada
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
pharmaand GmbHCompletedMultiple MyelomaCanada, Spain, United States, Czechia, Turkey, France, Sweden, Korea, Republic of, Thailand, Belgium, Greece, Germany, Hungary, Russian Federation, Italy, Poland, Australia, Lebanon, Portugal, Norway, Brazil, Netherlands
-
Paul Richardson, MDM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaboratorsActive, not recruiting
-
European Myeloma NetworkFondazione EMN Italy OnlusCompleted
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
CelgeneActive, not recruitingMultiple MyelomaAustria
-
University of ArkansasJanssen, LPActive, not recruitingMultiple MyelomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States, Puerto Rico
-
GlaxoSmithKlineActive, not recruiting
-
Sumitomo Pharma America, Inc.CompletedHematologic MalignancyUnited States
-
OncotherapeuticsCelgene CorporationTerminatedMultiple MyelomaUnited States
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterWithdrawn
-
European Myeloma NetworkEMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Greece, Italy
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
Stichting Hemato-Oncologie voor Volwassenen NederlandEuropean Myeloma Network; Gruppo Italiano Malattie EMatologiche dell'Adulto; DSMM... and other collaboratorsActive, not recruitingMultiple MyelomaSweden, Norway, Italy, Netherlands, Belgium, Switzerland, Australia, Denmark, Finland, Czechia, Turkey, Austria, Luxembourg, Hungary, Greece, Portugal
-
Arch OncologyCompletedMultiple MyelomaUnited States
-
University of ArkansasActive, not recruitingMyelomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Oncolytics BiotechCompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.Active, not recruitingMultiple MyelomaUnited States